GJB1 variants in Charcot‐Marie‐Tooth disease X‐linked type 1 in Mali

• Published in: Journal of the peripheral nervous system Vol. 27; no. 2; pp. 113 - 119
• Main Authors: Yalcouyé, Abdoulaye, Diallo, Seybou H., Cissé, Lassana, Karembé, Mamadou, Diallo, Salimata, Coulibaly, Thomas, Diarra, Salimata, Coulibaly, Dramane, Keita, Mohamed, Guinto, Cheick O., Fischbeck, Kenneth H., Wonkam, Ambroise, Landouré, Guida
• Format: Journal Article
• Language: English
• Published: Malden, USA Wiley Periodicals, Inc 01.06.2022
• Subjects: Africa; Charcot-Marie-Tooth Disease - pathology; CMTX1; Connexins - genetics; Gap Junction beta-1 Protein; GJB1; Humans; inherited neuropathies; Mali; Mutation - genetics; Mutation, Missense; Mali; GJB1; Mali; Africa; CMTX1; inherited neuropathies
• ISSN: 1085-9489; 1529-8027
• DOI: 10.1111/jns.12486

X‐linked Charcot‐Marie‐Tooth type 1 (CMTX1) disease is one of the most common subtypes of inherited neuropathies and is caused by mutations in the GJB1 gene. To date, more than 400 mutations have been reported in GJB1 worldwide but none in sub‐Saharan Africa (SSA). We aimed to clinically characterize patients with CMTX1 and identify the genetic defects. All patients were examined thoroughly, and Nerve Conduction Studies (NCS) were done. EEG and pure tone audiometry (PTA) were also done in select individuals having additional symptoms. DNA was extracted for CMT gene panel testing (50 genes + mtDNA and PMP22 duplication), and putative variants were screened in available relatives. The predominant starting symptom was tingling, and the chief complaint was gait difficulty. Neurological examination found a distal muscle weakness and atrophy, and sensory loss, skeletal deformities, decreased or absent reflexes and steppage gait. The inheritance pattern was consistent with dominant X‐linked. NCS showed no response in most of the tested nerves in lower limbs, and normal or reduced amplitudes in upper limbs. A severe sensorineural hearing impairment and a focal epileptic seizure were observed in one patient each. A high intra and inter‐familial clinical variability was observed. Genetic testing found three pathogenic missense variants in GJB1, one in each of the families (Val91Met, Arg15Trp, and Phe235Cys). This is the first report of genetically confirmed cases of CMTX1 in SSA, and confirms its clinical and genetic heterogeneity.